Inicio › Cáncer de ovario › Rhode Island
Ensayos clínicos de Cáncer de ovario en Rhode Island
16 estudios sobre Cáncer de ovario buscan participantes en Rhode Island.
Ciudades en Rhode Island
Texto oficial del estudio (inglés)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Women and Infants Hospital, Providence
- Roger Williams Medical Center, Providence
ReclutandoFase 2
Todas las edades · Todos los sexos · Actualizado el 2 oct 2026 · NCT05564377A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Women & Infants Hospital /ID# 277930, Providence
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 1 oct 2026 · NCT07024784TLR9 Immunotherapy for Peritoneal Carcinomatosis
- Rhode Island and the Miriam Hospitals (Brown University Health), Providence
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT07658196A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Women & Infants Hospital /ID# 274716, Providence
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 29 sept 2026 · NCT06890338A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Women & Infants Hospital, Providence
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07213804A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- Women & Infants Hospital ( Site 0001), Providence
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 17 sept 2026 · NCT07318558A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- Women & Infants Hospital ( Site 0050), Providence
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 3 sept 2026 · NCT06824467Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Research Site, Providence
ReclutandoFase 1/2
Edades de 18 a 130 · Todos los sexos · Actualizado el 21 ago 2026 · NCT05797168Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- Smilow Cancer Hospital Care Center - Westerly, Westerly
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT07001748A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Women and Infants Hospital, Providence
Reclutando
Edades de 35 a 50 · Mujeres · Actualizado el 7 ago 2026 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Women and Infants Hospital, Providence
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ago 2026 · NCT06580314Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Women and Infants Hospital of Rhode Island, Providence
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 ago 2026 · NCT05579366A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Lifespan Cancer Institute - Rhode Island Hospital, Providence
ReclutandoFase 2
Edades de 8 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT05503797Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
- Women's and Infant's Hospital, Providence
ReclutandoSe aceptan voluntarios sanos
Edades de 50 a 74 · Mujeres · Actualizado el 6 may 2026 · NCT00539162A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Site 0191, Providence
ReclutandoFase 1
Edades de 18 en adelante · Mujeres · Actualizado el 7 abr 2026 · NCT04516447SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Providence
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.